A Phase I Clinical Trial of OXi4503 for Relapsed and Refractory AML and MDS

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 2015 by University of Florida
Sponsor:
Collaborator:
The Leukemia and Lymphoma Society
Information provided by (Responsible Party):
University of Florida
ClinicalTrials.gov Identifier:
NCT01085656
First received: March 11, 2010
Last updated: February 6, 2015
Last verified: February 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2015
  Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)